Heterozygous NOTCH1 Variants Cause CNS Immune Activation and Microangiopathy.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
11 2022
Historique:
revised: 06 08 2022
received: 26 02 2022
accepted: 09 08 2022
pubmed: 11 8 2022
medline: 26 10 2022
entrez: 10 8 2022
Statut: ppublish

Résumé

NOTCH1 belongs to the NOTCH family of proteins that regulate cell fate and inflammatory responses. Somatic and germline NOTCH1 variants have been implicated in cancer, Adams-Oliver syndrome, and cardiovascular defects. We describe 7 unrelated patients grouped by the presence of leukoencephalopathy with calcifications and heterozygous de novo gain-of-function variants in NOTCH1. Immunologic profiling showed upregulated CSF IP-10, a cytokine secreted downstream of NOTCH1 signaling. Autopsy revealed extensive leukoencephalopathy and microangiopathy with vascular calcifications. This evidence implicates that heterozygous gain-of-function variants in NOTCH1 lead to a chronic central nervous system (CNS) inflammatory response resulting in a calcifying microangiopathy with leukoencephalopathy. ANN NEUROL 2022;92:895-901.

Identifiants

pubmed: 35947102
doi: 10.1002/ana.26477
doi:

Substances chimiques

Receptor, Notch1 0
Chemokine CXCL10 0
NOTCH1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

895-901

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022 American Neurological Association.

Références

Siebel C, Lendahl U. Notch signaling in development, tissue homeostasis, and disease. Physiol Rev 2017;97:1235-1294.
Stittrich AB, Lehman A, Bodian DL, et al. Mutations in NOTCH1 cause Adams-Oliver syndrome. Am J Hum Genet 2014;95:275-284.
Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004;306:269-271.
Hack RJ, Rutten J, Lesnik Oberstein SAJ. Cadasil. In: Adam MP, Mirzaa GM, Pagon RA, et al., eds. GeneReviews((R)). Seattle (WA): University of Washington, Seattle, 2019.
Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat 2015;36:928-930.
Aan de Kerk DJ, Jansen MH, Ten Berge IJ, et al. Identification of B cell defects using age-defined reference ranges for in vivo and in vitro B cell differentiation. J Immunol 2013;190:5012-5019.
Klok MD, Bakels HS, Postma NL, et al. Interferon-alpha and the calcifying microangiopathy in Aicardi-Goutieres syndrome. Ann Clin Transl Neurol 2015;2:774-779.
van Heteren JT, Rozenberg F, Aronica E, et al. Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in Aicardi-Goutieres syndrome. Glia 2008;56:568-578.
Outtz HH, Wu JK, Wang X, Kitajewski J. Notch1 deficiency results in decreased inflammation during wound healing and regulates vascular endothelial growth factor receptor-1 and inflammatory cytokine expression in macrophages. J Immunol 2010;185:4363-4373.
Gordon WR, Roy M, Vardar-Ulu D, et al. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. Blood 2009;113:4381-4390.
Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 2011;11:338-351.
Chiang MY, Xu L, Shestova O, et al. Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J Clin Invest 2008;118:3181-3194.
Livingston JH, Stivaros S, van der Knaap MS, Crow YJ. Recognizable phenotypes associated with intracranial calcification. Dev Med Child Neurol 2013;55:46-57.
Kang JA, Kim WS, Park SG. Notch1 is an important mediator for enhancing of B-cell activation and antibody secretion by Notch ligand. Immunology 2014;143:550-559.
Perez-Garcia C, Martin YR, Del Hoyo AA, et al. Adams-Oliver syndrome with unusual central nervous system findings and an extrahepatic portosystemic shunt. Pediatr Rep 2017;9:7211.
Vandersteen AM, Dixon JW. Adams-Oliver syndrome, a family with dominant inheritance and a severe phenotype. Clin Dysmorphol 2011;20:210-213.
Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005;437:270-274.
Jia H, Zhang K, Chen Q, et al. Downregulation of Notch-1/Jagged-2 in human colon tissues from Hirschsprung disease patients. Int J Colorectal Dis 2012;27:37-41.
Gilani A, Adang LA, Vanderver A, et al. Neuropathological findings in a case of IFIH1-related Aicardi-Goutieres syndrome. Pediatr Dev Pathol 2019;22:566-570.
Maheshwari U, Huang SF, Sridhar S, Keller A. The interplay between brain vascular calcification and microglia. Front Aging Neurosci 2022;14:848495.

Auteurs

Guy Helman (G)

Murdoch Children's Research Institute, The Royal Children's Hospital, Victoria, Australia.
Institute for Molecular Bioscience, The University of Queensland, Queensland, Australia.

Parand Zarekiani (P)

Department of Pathology, Amsterdam University Medical Centers, VU University Amsterdam and Amsterdam Neuroscience, Amsterdam, HV, The Netherlands.
Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, DD, The Netherlands.

Samantha A M Tromp (SAM)

Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, DD, The Netherlands.
Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, DD, The Netherlands.

Ashley Andrews (A)

Division of Medical Genetics, University of Utah, Salt Lake City, UT.

Lorenzo D Botto (LD)

Division of Medical Genetics, University of Utah, Salt Lake City, UT.

Joshua L Bonkowsky (JL)

Division of Pediatric Neurology, Department of Pediatrics, University of Utah, Salt Lake City, UT.

Anna Chassevent (A)

Division of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland.

Elisa Giorgio (E)

Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Medical Genetics Unit, IRCCS Mondino Foundation, Pavia, Italy.

Tommaso Pippucci (T)

U.O. Genetica Medica, IRCCS Azienda Ospedaliero - Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy.

Shen Wei (S)

Clinical Genome Sequencing Laboratory, Mayo Clinic, Rochester, MN.

Constance Smith-Hicks (C)

The Hugo Moser Research Institute at Kennedy Krieger, Baltimore, MD.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.

Giovanna Vaula (G)

Department of Neuroscience, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Turin, Italy.

Michèl A A P Willemsen (MAAP)

Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.

Mareike Schimmel (M)

Division of Pediatric Neurology, Childrens's Hospital, University Hospital Augsburg, Augsburg, Germany.

Kurt Vollert (K)

Department of Diagnostic Radiology and Neuroradiology - Pediatric Radiology Section, University Hospital Augsburg, Augsburg, Germany.

Fumitaka Shimizu (F)

Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Japan.

Takashi Kanda (T)

Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Japan.

Matthew Lynch (M)

Neurosciences Unit, Queensland Children's Hospital, Brisbane, Australia.
Queensland Lifespan Metabolic Medicine Service, Queensland Children's Hospital, Brisbane, Australia.

Tony Roscioli (T)

New South Wales Health Pathology Randwick Genomics Laboratory, Sydney, New South Wales, Australia.
Centre for Clinical Genetics, Sydney Children's Hospital, Sydney, New South Wales, Australia.
Neuroscience Research Australia (NeuRA), University of New South Wales, Sydney, New South Wales, Australia.

Ryan J Taft (RJ)

Illumina Inc., San Diego, California.

Cas Simons (C)

Murdoch Children's Research Institute, The Royal Children's Hospital, Victoria, Australia.
Institute for Molecular Bioscience, The University of Queensland, Queensland, Australia.

Marianna Bugiani (M)

Department of Pathology, Amsterdam University Medical Centers, VU University Amsterdam and Amsterdam Neuroscience, Amsterdam, HV, The Netherlands.
Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, DD, The Netherlands.

Taco W Kuijpers (TW)

Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, Amsterdam, DD, The Netherlands.
Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, DD, The Netherlands.

Marjo S van der Knaap (MS)

Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, DD, The Netherlands.
Department of Child Neurology, Emma Children's Hospital, Amsterdam University Medical Centers, VU University Amsterdam and Amsterdam Neuroscience, Amsterdam, The Netherlands.
Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH